Búsqueda de Publicación - Prisma - Unidad de Bibliometría

Publicaciones en la fuente JOURNAL OF CROHNS & COLITIS

Tipo Año Título Fuente
Artículo2022Management and long-term outcomes of Crohn's disease complicated with enterocutaneous fistula: ECUFIT study from GETECCUJOURNAL OF CROHNS & COLITIS
Artículo2022Multicriteria decision analysis for updating of quality indicators for inflammatory bowel disease comprehensive care units in SpainJOURNAL OF CROHNS & COLITIS
Artículo2022Risk of Immunomediated Adverse Events and Loss of Response to Infliximab in Elderly Patients with Inflammatory Bowel Disease: A Cohort Study of the ENEIDA RegistryJOURNAL OF CROHNS & COLITIS
Resumen congreso2022Therapeutic drug monitoring of infliximab in Crohn's disease: cut-off points during maintenance therapyJOURNAL OF CROHNS & COLITIS
Póster2020N10 Effectiveness of self-management workshop in inflammatory bowel diseases according to psychosocial profiles. Clinical trialJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Anti-TNFs patterns of use in clinical practice in inflammatory bowel disease (VERNE study)JOURNAL OF CROHNS & COLITIS
Resumen congreso2019Are cut-off ranges of Infliximab serum levels in Crohn's disease always the same in clinical practice?JOURNAL OF CROHNS & COLITIS
Resumen congreso2019Clinical follow-up of patients with Crohn's disease treated with ustekinumab in our hospitalJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Effectiveness and safety of the sequential use of a second and third anti-TNF agent in patients with inflammatory bowel disease: results from the ENEIDA registryJOURNAL OF CROHNS & COLITIS
Artículo2019Effectiveness and safety of the switch from Remicade (R) to CT-P13 in patients with inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2019How to incorporate patients preference into ulcerative colitis current clinical management: initial document from a Spanish multidisciplinary steering committeeJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Impact of co-morbidities on loss and lack of response to anti-TNFs in inflammatory bowel disease: VERNE studyJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multi-centre cohort study of the ENEIDA registryJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world dataJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Polyphenolic extract from Chilean berry attenuates intestinal damage and improves clinical indicators in an animal model of Crohn's diseaseJOURNAL OF CROHNS & COLITIS
Artículo2019Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre StudyJOURNAL OF CROHNS & COLITIS
Resumen congreso2019Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease: a cohort study of the ENEIDA registryJOURNAL OF CROHNS & COLITIS
Resumen congreso2018Comparison of the efficacy of infliximab biosimilar (Remsima (R)) vs. infliximab original (Remicade (R)) in patients with inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2018Differential characteristics of patients with inflammatory bowel disease onset in paediatric age compared with patients diagnosed in adulthood: Results from the CAROUSEL study of GETECCUJOURNAL OF CROHNS & COLITIS
Artículo2018Emergence of Inflammatory Bowel Disease During Treatment With SecukinumabJOURNAL OF CROHNS & COLITIS
Resumen congreso2018Motherhood and child care are negatively influenced by ulcerative colitis: patients' insights from the UC-LIFE surveyJOURNAL OF CROHNS & COLITIS
Póster2018N006 Psychosocial profiles in IBD according to the impairment risk of quality of lifeJOURNAL OF CROHNS & COLITIS
Resumen congreso2018Predictors of vedolizumab response to induction: Real-life experienceJOURNAL OF CROHNS & COLITIS
Ponencia2018Psychosocial profiles in IBD according to the impairment risk of quality of lifeJOURNAL OF CROHNS & COLITIS
Artículo2018Serial Tuberculin Skin Tests Improve the Detection of Latent Tuberculosis Infection in Patients With Inflammatory Bowel DiseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2018Switching from reference infliximab to CT-P13 in patients with inflammatory bowel disease: Multicentre study at 12 months resultsJOURNAL OF CROHNS & COLITIS
Resumen congreso2018The "other burden" of ulcerative colitis: Impact on social and professional life described by Spanish patientsJOURNAL OF CROHNS & COLITIS
Resumen congreso2018The availability of anti-TNF agents is associated with reduced early surgical requirements in Crohn's disease but not in ulcerative colitis. A nationwide study from the Eneida registryJOURNAL OF CROHNS & COLITIS
Resumen congreso2018The initiation of thiopurines in elderly patients with inflammatory bowel disease is associated with an increased risk of adverse effects: a case-control study of the ENEIDA registryJOURNAL OF CROHNS & COLITIS
Letter2018Using Vedolizumab to Treat Severe Sweet's Syndrome in a Patient With Ulcerative ColitisJOURNAL OF CROHNS & COLITIS
Artículo20173rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special SituationsJOURNAL OF CROHNS & COLITIS
Artículo2017Early Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in Patients with Inflammatory Bowel DiseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2017Evolution after a "de-intensification" strategy with anti-TNF therapy in patients with inflammatory bowel disease in clinical remission: multicenter studyJOURNAL OF CROHNS & COLITIS
Resumen congreso2017Long-term efficacy and safety of Cx601, allogeneic expanded adipose-derived mesenchymal stem cells, for complex perianal fistulas in Crohn's disease: 52-week results of a phase III randomised controlled trialJOURNAL OF CROHNS & COLITIS
Resumen congreso2017Modulation of the fecal metagenome in patients with Crohn's diseaseJOURNAL OF CROHNS & COLITIS
Póster2017N800 Statistical comparison of predictors of quality of life in inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Artículo2017Prevalence of Malnutrition and Nutritional Characteristics of Patients With Inflammatory Bowel DiseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2017Rapidity of onset of response to adalimumab in luminal Crohn's disease. Data from RAPIDA trialJOURNAL OF CROHNS & COLITIS
Ponencia2017Statistical comparison of predictors of quality of life in inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2016A phase III randomised controlled trial of Cx601, expanded allogeneic adipose-derived mesenchymal stem cells (eASC), for complex perianal fistulas in Crohn's diseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Evolution of the incidence of inflammatory bowel disease in the south of Spain in 2 periodsJOURNAL OF CROHNS & COLITIS
Resumen congreso2016More than 10 years of experience of use methotrexate in Crohn's disease at Macarena Hospital, Sevilla, SpainJOURNAL OF CROHNS & COLITIS
Resumen congreso2016More than 10 years of experience of use methotrexate in Ulcerative colitis at Macarena Hospital, Sevilla, SpainJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Patients' perceptions on patient-physician communication and influence of hospital size amongst Spanish patients with ulcerative colitis: UC-LIFE surveyJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Prevalence and factors associated with fatigue in patients with inflammatory bowel disease: a multicentre studyJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Real-life experience with golimumab in ulcerative colitis patients according to prior anti-TNF useJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Safety and efficacy of infliximab biosimilar (Remsima (c)) in Crohn's disease patients in clinical practice: results after 6 months of treatmentJOURNAL OF CROHNS & COLITIS
Resumen congreso2016Safety and efficacy of infliximab biosimilar (Remsima (c)) in ulcerative colitis disease patients in clinical practice: results after 6-months treatmentJOURNAL OF CROHNS & COLITIS
Resumen congreso2015Perception about disease activity and treatment attributes in patients with Ulcerative Colitis from Spain - UC-life surveyJOURNAL OF CROHNS & COLITIS
Resumen congreso2015Perception of social and emotional impact of Ulcerative Colitis by Spanish patients - UC-life surveyJOURNAL OF CROHNS & COLITIS
Resumen congreso2015Perception of the impact of Ulcerative Colitis in the quality of life of patients from Spain - UC-life surveyJOURNAL OF CROHNS & COLITIS
Resumen congreso2015Prognosis of patients with Ulcerative Colitis in remission after thiopurines withdrawalJOURNAL OF CROHNS & COLITIS
Ponencia2014Prospective study of prevalence and incidence of vertebral fractures in long-term anti-TNF alpha maintenance therapy treatment for inflammatory bowel diseaseJOURNAL OF CROHNS & COLITIS
Artículo2011Cutaneous lymphoma in a patient with ulcerative colitis after immunosuppressive therapyJOURNAL OF CROHNS & COLITIS